News Snapshot:
Bio Platforms, Formulation Development, Market News & Trends INmune Bio, Inc. Announces Research Collaboration With Chinese University of Hong Kong to Evaluate INKmune in Nasopharyngeal Cancer INmune Bio, Inc. recently announced the company has entered into a preclinical research collaboration with Chinese University of Hong Kong (CUHK) to evaluate INKmune – the company’s pseudokine NK cell priming platform – in nasopharyngeal cancer (NPC), a type of head and neck cancer. The Strategic Partnership Award for Research Collaboration, which was granted by the CUHK Office of Academic Links, is between Prof. Michael Tong at CUHK and Prof. Mark Lowdell at University...
